FDA lifting barriers to generic drug competition? Value based contracting. IPAB ends before it begins. RWJF: Better Care increases uninsured by 25 million What’s worse than high drug prices?
U.S. ranks poorly in differences in self-reported health by income. FDA pulls opioid off the market. Medicaid reform. Follow the money. Value frameworks and IVI Insurers now joining Obamacare?
ACA and healthcare spending. Risk adjustment and the ACA. Value framework harmonization? Is value-based pricing coming for drugs? “…it also caused mutations to more than a thousand other unintended genes“
Is big data eclipsing RCTs? Interview with Raj Chetty. Pink boxes in LA. Immunotherapy and precision medicine. The cost of high-risk pools.
Nocebo effect. AppleWatch can detect AFib. Canada to the US: We are not your drugstore. Senate on AHCA: “The House bill isn’t going to pass over here.” NHS docs: Max 1% raise until 2020.
Safety regulation: Unintended consequences in the NFL? Measles is back. Physicians, coding, and reimbursement. Is healthcare funding a game of hot potato? 70% of employers offer HDHP.
Does increasing MD reimbursement increase patient access to care? Cure for diabetes? A huge waste of money? The benefits of early treatment. A money-back guarantee.
Brad Wright has posted the Health Wonk Review: Who’s On First? Edition at Wright on Health. Check it out along with some other interesting links from the week. Consultants and policymakers. Superbabies. Blocks grants: Case study in Canada. A pact. Standards-based grading. Brand penalty.
Economics isn’t everything. Do airline classes reduce prices? Tiered pharmacies in California? More drug pricing transparancy. Cure for sepsis. Narrow networks.
VBID and medication adherence. eConsult. Do drugs reduce ED use during pregnancy? Mindfulness and managed care. Looming cuts to NIH.